Arjola Bano1,2,3, Klodian Dhana3,4, Layal Chaker1,2,3,5, Maryam Kavousi3, M Arfan Ikram3, Francesco U S Mattace-Raso1,6, Robin P Peeters1,2,3, Oscar H Franco3. 1. Department of Internal Medicine, Erasmus Medical Center, Rotterdam, the Netherlands. 2. Academic Center for Thyroid Diseases, Erasmus Medical Center, Rotterdam, the Netherlands. 3. Department of Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands. 4. Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, Massachusetts. 5. Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts. 6. Section of Geriatric Medicine, Erasmus Medical Center, Rotterdam, the Netherlands.
Abstract
Importance: Variations in thyroid function within reference ranges are associated with an increased risk of cardiovascular disease (CVD) and mortality. However, the impact of thyroid function on life expectancy (LE) and the number of years lived with and without CVD remains unknown. Objective: To investigate the association of thyroid function with total LE and LE with and without CVD among euthyroid individuals. Design, Setting, and Participants: The Rotterdam Study, a population-based, prospective cohort study. We included participants without known thyroid disease and with thyrotropin and free thyroxine (FT4) levels within the reference ranges. Main Outcomes and Measures: Multistate life tables were used to calculate total LE and LE with and without CVD among thyrotropin and FT4 tertiles. Life expectancy estimates in men and women aged 50 years and older were obtained using prevalence, incidence rates, and hazard ratios for 3 transitions (healthy to CVD, healthy to death, and CVD to death), adjusting for sociodemographic and cardiovascular risk factors. Results: The mean (SD) age of the 7785 participants was 64.7 (9.8) years, and 52.5% were women. Over a median follow-up of 8.1 (interquartile range, 2.7-9.9) years, we observed 789 incident CVD events and 1357 deaths. Compared with those in the lowest tertile, men and women in the highest thyrotropin tertile lived 2.0 (95% CI, 1.0 to 2.8) and 1.4 (95% CI, 0.2 to 2.4) years longer, respectively, of which, 1.5 (95% CI, 0.2 to 2.6) and 0.9 (95% CI, -0.2 to 2.0) years longer without CVD. Compared with those in the lowest tertile, the difference in life expectancy for men and women in the highest FT4 tertile was -3.2 (95% CI, -5.0 to -1.4) and -3.5 (95% CI, -5.6 to -1.5) years, respectively, of which, -3.1 (95% CI, -4.9 to -1.4) and -2.5 (95% CI, -4.4 to -0.7) years without CVD. Conclusions and Relevance: At the age of 50 years, participants with low-normal thyroid function live up to 3.5 years longer overall and up to 3.1 years longer without CVD than participants with high-normal thyroid function. These findings provide supporting evidence for a reevaluation of the current reference ranges of thyroid function and can help inform preventive and clinical care.
Importance: Variations in thyroid function within reference ranges are associated with an increased risk of cardiovascular disease (CVD) and mortality. However, the impact of thyroid function on life expectancy (LE) and the number of years lived with and without CVD remains unknown. Objective: To investigate the association of thyroid function with total LE and LE with and without CVD among euthyroid individuals. Design, Setting, and Participants: The Rotterdam Study, a population-based, prospective cohort study. We included participants without known thyroid disease and with thyrotropin and free thyroxine (FT4) levels within the reference ranges. Main Outcomes and Measures: Multistate life tables were used to calculate total LE and LE with and without CVD among thyrotropin and FT4 tertiles. Life expectancy estimates in men and women aged 50 years and older were obtained using prevalence, incidence rates, and hazard ratios for 3 transitions (healthy to CVD, healthy to death, and CVD to death), adjusting for sociodemographic and cardiovascular risk factors. Results: The mean (SD) age of the 7785 participants was 64.7 (9.8) years, and 52.5% were women. Over a median follow-up of 8.1 (interquartile range, 2.7-9.9) years, we observed 789 incident CVD events and 1357 deaths. Compared with those in the lowest tertile, men and women in the highest thyrotropin tertile lived 2.0 (95% CI, 1.0 to 2.8) and 1.4 (95% CI, 0.2 to 2.4) years longer, respectively, of which, 1.5 (95% CI, 0.2 to 2.6) and 0.9 (95% CI, -0.2 to 2.0) years longer without CVD. Compared with those in the lowest tertile, the difference in life expectancy for men and women in the highest FT4 tertile was -3.2 (95% CI, -5.0 to -1.4) and -3.5 (95% CI, -5.6 to -1.5) years, respectively, of which, -3.1 (95% CI, -4.9 to -1.4) and -2.5 (95% CI, -4.4 to -0.7) years without CVD. Conclusions and Relevance: At the age of 50 years, participants with low-normal thyroid function live up to 3.5 years longer overall and up to 3.1 years longer without CVD than participants with high-normal thyroid function. These findings provide supporting evidence for a reevaluation of the current reference ranges of thyroid function and can help inform preventive and clinical care.
Authors: Annewieke W van den Beld; Theo J Visser; Richard A Feelders; Diederick E Grobbee; Steven W J Lamberts Journal: J Clin Endocrinol Metab Date: 2005-09-20 Impact factor: 5.958
Authors: M P Rozing; J J Houwing-Duistermaat; P E Slagboom; M Beekman; M Frölich; A J M de Craen; R G J Westendorp; D van Heemst Journal: J Clin Endocrinol Metab Date: 2010-08-25 Impact factor: 5.958
Authors: Danka J F Stuijver; Bregje van Zaane; Erica Romualdi; Dees P M Brandjes; Victor E A Gerdes; Alessandro Squizzato Journal: Thromb Haemost Date: 2012-09-26 Impact factor: 5.249
Authors: Graziano Ceresini; Gian Paolo Ceda; Fulvio Lauretani; Marcello Maggio; Elisa Usberti; Michela Marina; Stefania Bandinelli; Jack M Guralnik; Giorgio Valenti; Luigi Ferrucci Journal: J Am Geriatr Soc Date: 2013-05-06 Impact factor: 7.538
Authors: Carolina Castro Porto Silva Janovsky; Fernando H Cesena; Viviane Arevalo Tabone Valente; Raquel Dilguerian de Oliveira Conceição; Raul D Santos; Márcio Sommer Bittencourt Journal: Eur Thyroid J Date: 2018-08-29
Authors: Antoine Stier; Bin-Yan Hsu; Coline Marciau; Blandine Doligez; Lars Gustafsson; Pierre Bize; Suvi Ruuskanen Journal: Biol Lett Date: 2020-11-11 Impact factor: 3.703
Authors: Enoch J Abbey; John McGready; Luigi Ferrucci; Eleanor M Simonsick; Jennifer S R Mammen Journal: J Am Geriatr Soc Date: 2021-01-08 Impact factor: 7.538
Authors: M Arfan Ikram; Guy Brusselle; Mohsen Ghanbari; André Goedegebure; M Kamran Ikram; Maryam Kavousi; Brenda C T Kieboom; Caroline C W Klaver; Robert J de Knegt; Annemarie I Luik; Tamar E C Nijsten; Robin P Peeters; Frank J A van Rooij; Bruno H Stricker; André G Uitterlinden; Meike W Vernooij; Trudy Voortman Journal: Eur J Epidemiol Date: 2020-05-04 Impact factor: 8.082
Authors: Pranati L Panuganti; Stefanie N Hinkle; Shristi Rawal; Louise G Grunnet; Yuan Lin; Aiyi Liu; Anne C B Thuesen; Sylvia H Ley; Sjurdur F Olesen; Cuilin Zhang Journal: Nutrients Date: 2018-07-21 Impact factor: 5.717
Authors: Alexander Teumer; Layal Chaker; Stefan Groeneweg; Yong Li; Celia Di Munno; Caterina Barbieri; Ulla T Schultheiss; Michela Traglia; Tarunveer S Ahluwalia; Masato Akiyama; Emil Vincent R Appel; Dan E Arking; Alice Arnold; Arne Astrup; Marian Beekman; John P Beilby; Sofie Bekaert; Eric Boerwinkle; Suzanne J Brown; Marc De Buyzere; Purdey J Campbell; Graziano Ceresini; Charlotte Cerqueira; Francesco Cucca; Ian J Deary; Joris Deelen; Kai-Uwe Eckardt; Arif B Ekici; Johan G Eriksson; Luigi Ferrrucci; Tom Fiers; Edoardo Fiorillo; Ian Ford; Caroline S Fox; Christian Fuchsberger; Tessel E Galesloot; Christian Gieger; Martin Gögele; Alessandro De Grandi; Niels Grarup; Karin Halina Greiser; Kadri Haljas; Torben Hansen; Sarah E Harris; Diana van Heemst; Martin den Heijer; Andrew A Hicks; Wouter den Hollander; Georg Homuth; Jennie Hui; M Arfan Ikram; Till Ittermann; Richard A Jensen; Jiaojiao Jing; J Wouter Jukema; Eero Kajantie; Yoichiro Kamatani; Elisa Kasbohm; Jean-Marc Kaufman; Lambertus A Kiemeney; Margreet Kloppenburg; Florian Kronenberg; Michiaki Kubo; Jari Lahti; Bruno Lapauw; Shuo Li; David C M Liewald; Ee Mun Lim; Allan Linneberg; Michela Marina; Deborah Mascalzoni; Koichi Matsuda; Daniel Medenwald; Christa Meisinger; Ingrid Meulenbelt; Tim De Meyer; Henriette E Meyer Zu Schwabedissen; Rafael Mikolajczyk; Matthijs Moed; Romana T Netea-Maier; Ilja M Nolte; Yukinori Okada; Mauro Pala; Cristian Pattaro; Oluf Pedersen; Astrid Petersmann; Eleonora Porcu; Iris Postmus; Peter P Pramstaller; Bruce M Psaty; Yolande F M Ramos; Rajesh Rawal; Paul Redmond; J Brent Richards; Ernst R Rietzschel; Fernando Rivadeneira; Greet Roef; Jerome I Rotter; Cinzia F Sala; David Schlessinger; Elizabeth Selvin; P Eline Slagboom; Nicole Soranzo; Thorkild I A Sørensen; Timothy D Spector; John M Starr; David J Stott; Youri Taes; Daniel Taliun; Toshiko Tanaka; Betina Thuesen; Daniel Tiller; Daniela Toniolo; Andre G Uitterlinden; W Edward Visser; John P Walsh; Scott G Wilson; Bruce H R Wolffenbuttel; Qiong Yang; Hou-Feng Zheng; Anne Cappola; Robin P Peeters; Silvia Naitza; Henry Völzke; Serena Sanna; Anna Köttgen; Theo J Visser; Marco Medici Journal: Nat Commun Date: 2018-10-26 Impact factor: 14.919